Chanelle founder invests €100k in Redesdale Group

Michael Burke has taken a stake in a firm that will seek to acquire or invest in early stage food and wellness businesses

21st February, 2021
Chanelle founder invests €100k in Redesdale Group
Michael Burke: managing director of Chanelle Pharmaceuticals. Picture: Michael Dillon

Michael Burke, the founder of Chanelle Pharmaceuticals, has joined veteran financier John Conroy’s Redesdale Group as a shareholder.

Set up by Conroy, the Merrion Capital founder, and formerly called Acton Health & Wellness Fund, Redesdale Group is expected to close an initial funding round in the region of €25 million later this quarter, sources familiar with the venture said.

Burke has invested in the region of €100,000 as part of his involvement in...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Related Stories

‘I always had entrepreneurial ambitions and this was first-hand evidence of an unmet need’

PM Group reports 30% profits increase and announces 200 new jobs in Ireland

Neuromod Devices to double Irish headcount within next year

Malin shareholders in line for windfall after €119 million cash boost